Axcan Pharma Inc.
Axcan Pharma Inc. company develops and sells drugs mainly to treat gastrointestinal ailments. Its Urso line treats chronic liver disease, while two of its products (Canasa and Salofalk) offer relief for inflammatory bowel diseases. Axcan's Ultrase and Viokase are digestive aids for patients with exocrine pancreatic insufficiency, a condition associated with cystic fibrosis. The firm also owns the global rights to Photofrin, a photodynamic drug developed by QLT with applications for esophageal, gastric, and lung cancers. Other products include ulcer and diarrhea treatments, as well as chewable multivitamins. Axcan was acquired by TPG Capital for $1.3 billion in early 2008.
Contact Details
Office Address
Axcan Pharma Inc.
597 Laurier Boulevard
Mont-Saint-Hilaire, Quebec, Canada J3H6C4
Phone: (450) 467-5138
Fax: (450) 464-9979
Executives
EVP and COO
David W. Mims
SVP and CFO
Steven R. (Steve) Gannon